| Ytd | -65.01% | |
| 1y | -82.30% |
| Open | 3.25 | Prev Close | 3.29 | Low | 3.15 | High | 3.52 | Mkt Cap | 6.83M |
| Vol | 76.32K | Avg Vol | 52.88K | EPS | -5.10 | P/E | N/A | Forward P/E | -5.64 |
| Beta | 1.06 | Short Ratio | 2.34 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 8.16 | 200-d Avg | 10.34 | 1yr Est | 10.00 |
LEXX News
Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday&#
Kelowna, British Columbia – September 17, 2026 - TheNewswire - Lexaria Bioscience Corp. (NASDAQ:LEXX
KELOWNA, BC / ACCESS Newswire / September 17, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Co
Gainers Circle8 Group (NASDAQ:CIRC) stock moved upwards by 14.6% to $0.57 during Monday's after
Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday'
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 76.4% to $4.3 during Thursday's regu
Gainers Opus Genetics (NASDAQ:IRD) shares increased by 31.7% to $5.71 during Wednesday's regula
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's
U.S. stocks fell Tuesday as health care lagged, while energy gained. ABM beat estimates; oil rose, a
U.S. stocks fell Tuesday, led by a 450-point Dow drop; health care slid while energy rose. NFIB opti
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market s
Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innova
Proprietary DehydraTECH 3.0 amycretin tablet formulation more than doubled absolute bioavailability